REFERENCES
- Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed. (DSM-III). Washington, DC: American Psychiatric Association, 1980.
- Bayer AJ, Roberts NA, Allen EA, et al. The pharmacokinetics of paroxetine in the elderly. Acta Psychiatr Scand 1989; 80: 85–86.
- Blazer DG, Birchett G, Service C, George LC. The association of age and depression among the elderly: An epidemiologic exploration. J Gerontol 1991; 46: 210–215.
- Bond J, Atkinson A, Gregson BA. The prevalence of psychiatric illness among continuing-care patients under the care of departments of geriatric medicine. Int J Geriatr Psychiatr 1989; 4: 227–233.
- Clement J-P, Leger JM. Clinique et épidémiologie de la dépression des sujets âgées. In: Les Dépressions des Sujets Ágés. Paris, Masson Editions, 1996, pp. 19–30.
- Dechant KL, Clissold SP. Paroxetine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs 1991; 2: 225–253.
- Dunbar GC. Paroxetine in the elderly: A comparative meta-analysis against standard antidepressant pharmacotherapy. Pharmacology 1995; 51: 137–144.
- Dunner DL. Therapeutic considerations in treating depression in the elderly. J Clin Psychiatry 1994; 55(Suppl 2): 48–58.
- Dunner DL, Dunbar GC. Optimal dose for paroxetine. J Clin Psychiatry 1992; 53(Suppl 2): 21–26.
- Fuhrer R, Antonucci TC, Gagnon M, et al. Depressive symptomatology and cognitive functioning: An epidemiological survey in an elderly community sample in France. Psychol Med 1992; 22: 159–172.
- Ghose K. The pharmacokinetics of paroxetine in elderly depressed patients. Acta Psychiatr Scand 1989; 80(Suppl 350): 87–88.
- Guy W. ECDEU Assessment Manual. Rockville, MD: National Institute of Mental Health, 1976.
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.
- Kivela SL, Pahkela K, Laippala P. Prevalence of depressionin an elderly population in Finland. Acta Psychiatr Scand 1988; 78: 401–413.
- Koenig HG, Cohen HJ, Blazer DG, Krishnan KRR, Siberts TE. Profile of depressive symptoms in younger and older medical inpatients with major depression. J Am Geriatr Soc 1993; 41: 1169–1176.
- Macgreevey JF, Franco K. Depression in the elderly: The role of the primary care physician in management. J Gen Intern Med 1988; 3: 498–507.
- Malauzat D, Thérapeutiques biologiques de la dépression du sujet âgé. In: Les Dépressions des Sujets Ágés. Paris, Masson Editions, 1996, pp. 95–114.
- Mann AH, Blanchard M, Waterreus. Depression in older people: Some criteria for effective treatment. L'Encéphale 1993; 19: 445–450.
- Mittmann N, Herrmann N, Einarson TR, et al. The efficacy, safety and tolerability of antidepressants in late life depression: A meta-analysis. J Affect Disord 1997; 46: 191–217.
- Murrell SA, Himmelfarb SA, Wright K. Prevalence of depression and its correlates in older adults. Am J Epidemiol 1983; 117: 173–185.
- Nies A, Robinson DS, Friedman MJ, et al. Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 1977; 134: 790–793.
- Orengo CA, Kunik ME, Molinari V, Workman RH. The use and tolerability of fluoxetine in geropsychiatric inpatients. J Clin Psychiatry 1996; 57: 12–16.
- Roose SP, Glassman AH, Attia E, Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151: 1735–1739.
- Salzman C. Pharmacologic treatment of depression in the elderly. J Clin Psychiatry 1993; 54 (Suppl 2): 23–28.
- Skoog I. The prevalence of psychotic, depressive, and anxiety syndromes in demented and non-demented 85-year-olds. Int J Geriatr Psychiatry 1993; 8: 247–253.
- Widlöcher D. Psychomotor retardation: Clinical, theoretical, and psychometric aspects. Psychiatr Clin N America 1983; 6: 27–40.